Treatment of Orthostatic Intolerance
Public ClinicalTrials.gov record NCT00262470. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder.
Study identification
- NCT ID
- NCT00262470
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- Acetazolamide Drug
- Atomoxetine Drug
- NO Drug Other
- Clonidine Drug
- Entacapone Drug
- Entacapone & Propranolol Drug
- Atomoxetine & Propranolol Drug
- Indomethacin Drug
- Mecamylamine Drug
- Isosorbide Dinitrate Drug
- Melatonin Dietary Supplement
- Midodrine Drug
- Modafinil Drug
- Octreotide Drug
- Placebo Radiation
- Propranolol Drug
- Modafinil & Propranolol Drug
- Sertraline Drug
- IV Saline Procedure
- Drinking Water Other
- Breathing Device Device
- memantine Drug
- Abdominal binder Device
Drug · Other · Dietary Supplement + 3 more
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1997 (Actual)
- Primary completion
- Dec 2029 (Estimated)
- Completion
- Dec 2029 (Estimated)
- Last update posted
- Oct 16, 2026
1997 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University Autonomic Dysfunction Center | Nashville | Tennessee | 37232-2195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00262470, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00262470 live on ClinicalTrials.gov.